Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

Delayed Diagnosis and Diagnostic Imprinting in Pediatric CNS Tumors:…

Ibrahim Qaddoumi

cfDNA for Liquid Biopsy for Patients With Glioblastoma

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

S. Bagley

2024 Neuro-Oncology Update: Brain Tumors

Scripps Health

T. McGranahan

Overview of CNS Cancers

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

V. Venur

Overview and Updates in Brain Tumors

Henry Friedman

Clinical Implications of Tumor Agnostic Therapies

Shivaani Kummar

Year in Review 2024 - Top Clinical Trials in Neuro-Oncology

Oncology 2024 Year in Review

S. Bagley

Best Practices for the Provider Approach in Treating Patients With I…

Katherine Peters

RANO 2.0 and Advances in Neuroimaging: Impact on Clinical Trials and…

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

S. Mohan

Effective Strategies for Managing IDH-Mutant Gliomas

Matteo Simonelli

IDH-Mutant Diffuse Glioma: Best Practices for Multidisciplinary Appr…

Ruham Nasany

Diagnosing IDH-Mutant Diffuse Glioma: Recent Classification Updates …

Ashley Aaroe

Surgical Approaches for Brain Tumors

Dana-Farber Cancer Institute

W. Linda Bi, O. Arnaout

ASCO® 2024 Insights: "FIREFLY-1 Trial - Type II RAF Inhibitor Tovora…

2024 ASCO® Annual Meeting Insights Hub

D. Ziegler

Key Practice-Changing Studies in Neuro-Oncology: Rapid Insights Acro…

Yale Cancer Center

N. Blondin

Medical and Symptom Management of Patients With Brain Tumors

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

A. Pruitt

Overcoming Barriers to Extend Survival: Promising Results of Clinica…

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

S. Brem

Getting Ahead of the ALS Curve: Early Detection and Intervention

i3 Health

S. Paganoni

Seizure Management for Brain Tumor Survivors: Current Concepts

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

S. Sinha